BIOGAS — Biokraft International AB Income Statement
0.000.00%
Last trade - 00:00- SEK871.58m
- SEK1.64bn
- SEK445.83m
Annual income statement for Biokraft International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 364 | 338 | 394 | 367 | 446 |
| Cost of Revenue | |||||
| Gross Profit | 183 | 158 | 220 | 181 | 190 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 365 | 344 | 389 | 432 | 519 |
| Operating Profit | -1.94 | -6.04 | 4.99 | -65.2 | -73.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -63.2 | -64.5 | -45.5 | -95.4 | -172 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -55.9 | -63.2 | -38.7 | -84.9 | -159 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -42.5 | -56.8 | -34.1 | -81.9 | -160 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -42.5 | -56.8 | -34.1 | -81.9 | -160 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.4 | -1.51 | -1.03 | -1.95 | -3.65 |
| Dividends per Share |